Virology Specimen Collection Market

• Rise in the prevalence of viral diseases is driving the market growth

One of the main factors driving up the demand for efficient virology specimen collection is the increased prevalence of viral infections like AIDS, the flu, SARS-CoV-2, EBOLA, STDs, and the Zika virus. The World Health Organisation (WHO) estimates that at the end of 2020, there were 37.7 million HIV-positive persons worldwide. Out of these, the WHO African Region was home to over two-thirds (25.4 million) of the population. In 2020, 1.5 million (1.0-2.0 million) individuals contracted the illness, and around 680,000 people perished from HIV-related causes.

Additionally, according to information released by the World Health Organisation (WHO) in July 2021, there were reportedly 7 million new cases of syphilis worldwide in 2020. Over 1 million sexually transmitted diseases (STIs) are contracted every day worldwide, according to data released by the World Health Organisation (WHO) in November 2021. This is then expected to further fuel the market for virology specimen collection.

Nasopharyngeal (NP) swabs are expected to increase in popularity as antigen tests become available to close timing and capacity limitations in the testing landscape. The appearance of the infectious Delta version of COVID-19 has also raised the need for tests in recent months. For instance, in August 2020, the US Department of Defence awarded a contract worth USD 51 million to Puritan Medical Products (US) in coordination with the Department of Health and Human Services (HHS).

The money is intended to help the company increase its monthly production capacity of flock tip testing swabs to 50 million swabs by March 2021 to facilitate coronavirus testing.

In addition, the rising incidence of viral diseases and the appearance of new pathogens are anticipated to be the main drivers of the market's expansion. The World Health Organisation (WHO) estimates that in 2021, various infectious diseases affected 60% of the world's population. The need for virology specimen collection has increased as a result of the expanding prevalence of viral infections such the human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other STDs. 

The Human Immunodeficiency Virus (HIV) was present in 38.4 million people as of the World Health Organization's (WHO) January 2021 update. Likewise, according to a Food and Agriculture Organisation (FAO) report released in January 2022, China recorded 13 new instances of the avian influenza virus while the United Kingdom reported 5 cases. Due to the effective detection and treatment of viral illnesses, the rising frequency of viral diseases and the advent of new viral infections has increased the demand for virology specimen collections, which will drive the market's growth during the ensuing years.

Thus, driving the Virology Specimen Collection market revenue.

The Global Virology Specimen Collection Market Industry is projected to experience substantial growth over the next decade. With a market value anticipated to reach 6.42 USD Billion in 2024 and further escalate to 11.3 USD Billion by 2035, the industry is poised for a robust expansion. The compound annual growth rate (CAGR) of 5.31% from 2025 to 2035 indicates a sustained upward trajectory, driven by factors such as technological advancements, increased demand for testing, and enhanced government support. This growth reflects the critical role of specimen collection in addressing global health challenges and improving disease management.

The shift towards personalized medicine is influencing the Global Virology Specimen Collection Market Industry, as healthcare providers seek tailored treatment approaches based on individual patient profiles. This trend necessitates precise specimen collection methods to ensure accurate diagnostics and treatment plans. As healthcare systems increasingly adopt personalized strategies, the demand for high-quality specimens is expected to rise. This evolution in medical practice underscores the importance of reliable specimen collection, which is essential for the successful implementation of personalized therapies. Consequently, this focus on individualized care may drive market expansion in the coming years.

Government initiatives aimed at improving public health infrastructure are significantly impacting the Global Virology Specimen Collection Market Industry. Increased funding for virology research and specimen collection programs is being observed globally, as governments recognize the importance of preparedness against viral outbreaks. This financial support facilitates the development of better collection protocols and training for healthcare professionals. Furthermore, public health campaigns are raising awareness about the importance of specimen collection in disease management. Such initiatives are likely to bolster market growth, as they enhance the capacity for effective viral surveillance and response.

The Global Virology Specimen Collection Market Industry is experiencing heightened demand for infectious disease testing, driven by the increasing prevalence of viral infections. As healthcare systems worldwide prioritize early detection and diagnosis, the market is projected to reach 6.42 USD Billion in 2024. This surge is indicative of a broader trend towards proactive healthcare measures, where timely specimen collection plays a crucial role in managing outbreaks and ensuring public health safety. Enhanced awareness among populations regarding viral diseases further fuels this demand, suggesting a sustained growth trajectory for the industry.

Emerging markets are playing a pivotal role in the Global Virology Specimen Collection Market Industry, as global health initiatives aim to enhance disease surveillance and response capabilities. Countries in regions such as Africa and Southeast Asia are receiving increased attention due to their vulnerability to viral outbreaks. International collaborations and funding are being directed towards improving specimen collection infrastructure in these areas, which is crucial for effective disease monitoring. As these markets develop their healthcare systems, the demand for virology specimen collection is likely to grow, contributing to the overall expansion of the industry.

Technological innovations are transforming the Global Virology Specimen Collection Market Industry, with advancements in collection methods enhancing efficiency and accuracy. Novel devices and automated systems are being developed to streamline specimen collection processes, thereby reducing the risk of contamination and improving sample integrity. For instance, the introduction of self-collection kits has empowered patients to participate in their own healthcare, potentially increasing testing rates. As these technologies continue to evolve, they are likely to contribute to the market's growth, which is expected to reach 11.3 USD Billion by 2035, reflecting a robust CAGR of 5.31% from 2025 to 2035.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Virology Specimen Collection Market dominated this market in 2022 (45.80%). Laboratory Corporation of America (LabCorp) will be the first diagnostic test developer for an at-home specimen collection kit for COVID-19, according to the US Food and Drug Administration (FDA), in April 2020. During the projected period, it is anticipated that this will increase demand for virology specimen collection throughout the region. Further, the U.S.

Virology Specimen Collection market held the largest market share, and the Canada Virology Specimen Collection market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: VIROLOGY SPECIMEN COLLECTION MARKET SHARE BY REGION 2022 (USD Billion) 

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Virology Specimen Collection market accounted for the healthy market share in 2022. The World Health Organisation (WHO) and the European Centre for Disease Prevention and Control (ECDC) are cooperating closely to determine the laboratory needs and capacities in the European region, according to the WHO's January 2020 report. As a result of the growth in COVID-19 cases and the occurrence of viral infections, sample collection kits are needed for laboratory tests and detection.

This is anticipated to fuel the market's expansion for virology specimen collection.Further, the German Virology Specimen Collection market held the largest market share, and the U.K Virology Specimen Collection market was the fastest growing market in the European region.

The Asia Pacific Virology Specimen Collection market is expected to register significant growth from 2023 to 2032. The Asian Development Bank (ADB) announced in April 2021 a USD 31.6 billion aid package for the Asia and Pacific area in 2020 to address the epidemic and boost green and sustainable green recovery in response to the outbreak of COVID-19 infections. Therefore, the virology specimen collecting market is anticipated to rise as a result of an increase in government financing.

Moreover, China’s Virology Specimen Collection market held the largest market share, and the Indian Virology Specimen Collection market was the fastest growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Virology Specimen Collection market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Virology Specimen Collection Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Virology Specimen Collection Industry to benefit clients and increase the market sector. In recent years, the Virology Specimen Collection Industry has offered some of the most significant advantages to medicine.

Major players in the Virology Specimen Collection market, including Hardy Diagnostics, Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., BNTX Inc., Formlabs, Medline Industries, Inc., Laboratory Corporation of America Holdings, VIRCELL S.L., Lucence Diagnostics Pte Ltd., and HiMedia Laboratories, are attempting to increase market demand by investing in research and development operations.

The company Covaris, LLC creates sophisticated sample preparation tools for genomic and proteomic research. The business provides technologies for tools, kits, tubes and vials, reagents, and accessories, enabling customers to discover new things, create new assays, and enhance bioanalytical outcomes. The truXTRAC viral RNA extraction kit and the truXTRAC-PCR direct viral RNA extraction kit are two new kits that Covaris, LLC introduced in February 2020 for the extraction of viral RNA from nose or throat swab sample collecting devices.

For tests like COVID-19, Rhinostics creates sample collecting kits to improve the productivity, accuracy, and security of labs. In comparison to traditional sample collecting methods, the company's patient-centric sample collection offers efficiencies to the laboratory that remove costs and save time, allowing labs to cut time and labour costs, increase safety, reduce sample contamination, and lower error rates. With the introduction of the VERIstic collection equipment designed specifically for tiny volume blood collection in the United States in July 2022, Rhinostics made a significant advancement in automated sample collection technology.